News & Updates

Serum urate lowering confers protection against fracture in gout
Serum urate lowering confers protection against fracture in gout
29 Mar 2023

Among people with gout, reducing serum urate levels to the guideline-based target level appears to contribute to a protective effect on the risk of incident fracture, according to a study.

Serum urate lowering confers protection against fracture in gout
29 Mar 2023
Ageing linked to seronegativity in RA
Ageing linked to seronegativity in RA
29 Mar 2023

Ageing is independently associated with seronegative rheumatoid arthritis (RA) in patients who are female, have a nonsmoking history, and a body mass index (BMI) <25 kg/m2, according to a study.

Ageing linked to seronegativity in RA
29 Mar 2023
Short-term risk of certain cancers similar in RA, PsA patients treated with JAK, TNF inhibitors
Short-term risk of certain cancers similar in RA, PsA patients treated with JAK, TNF inhibitors
12 Mar 2023

For patients with rheumatoid arthritis (RA) or psoriatic arthritis (PsA), initiation of Janus kinase (JAK) inhibitor treatment does not carry a higher short-term risk of cancer, with the exception of nonmelanoma skin cancer (NMSC), as compared with initiation of biological disease-modifying antirheumatic drugs (bDMARDs) including tumour necrosis factor (TNF) inhibitors, according to a study.

Short-term risk of certain cancers similar in RA, PsA patients treated with JAK, TNF inhibitors
12 Mar 2023